Central nervous system penetration and efficacy of targeted therapies used in non-small cell lung cancer and melanoma with brain metastases

Sidra Khalid, Aariez Khalid, Abdo Haddad, Timothy Spiro, Hamed Daw


Recently, many targeted therapies have been approved for treating brain metastases in non-small cell lung cancer and melanoma patients. In this article, the targeted therapies and their mechanism of action will be reviewed. It will highlight the central nervous system penetration of the targeted therapies. The article will also relate the efficacy of these drugs as seen in clinical trials, which would help guide clinicians when managing these patients. 

Full Text:


DOI: https://doi.org/10.5430/jst.v8n2p13

Journal of Solid Tumors

ISSN 1925-4067(Print)   ISSN 1925-4075(Online)

Copyright © Sciedu Press

To make sure that you can receive messages from us, please add the 'Sciedupress.com' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.